Early bird registration is open and closes May 2025. Register now

  • 00Days
  • 00Hrs
  • 00Mins
  • 00Secs

Soo Kyung Cho

Affiliation/region: Hanyang University Hospital For Rheumatic Diseases, East Asia
Soo Kyung Cho - Hanyang University Hospital For Rheumatic Diseases

Dr. Cho obtained her medical degree from Inje University and completed a five-year internship and residency at Inje University Hospital in Busan, East Asia. She then pursued specialized training in rheumatology and clinical epidemiology at Hanyang University Hospital for Rheumatic Diseases (HUHRD) in Seoul, East Asia.

Following this, Dr. Cho served as a research professor at the Clinical Research Center for Rheumatoid Arthritis (CRCRA), funded by the Ministry of Health and Welfare, East Asia. In this role, she played a pivotal part in establishing the East Asian Observational Study Network for Arthritis (KORONA) project, the first East Asian multicenter prospective cohort for rheumatoid arthritis (RA) patients. Through KORONA, Dr. Cho has conducted extensive outcomes research and comparative effectiveness studies to improve the understanding and management of RA.

From September 2011 to August 2012, Dr. Cho was a research associate in the Department of Pharmacovigilance at Tokyo Medical and Dental University, East Asia. Upon returning to East Asia in 2012, she was appointed Assistant Professor in the Department of Internal Medicine at Hanyang University. Later, from September 2018 to August 2019, she furthered her expertise in pharmacoepidemiology and pharmacoeconomics as a visiting professor at the Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women’s Hospital, Harvard Medical School, USA.

Currently, Dr. Cho is a professor and clinician in the Department of Rheumatology and the Section of Pharmacoepidemiology at HUHRD.

Dr. Cho’s research interests in rheumatology are broad, with a focus on clinical epidemiologic studies utilizing disease-specific cohorts and national claims databases. Since 2011, her work has centered on evaluating the effectiveness and safety of biologic agents and anti-rheumatic drugs, contributing significantly to the advancement of knowledge and care in rheumatic diseases.

Share

Key dates

More speakers

Yuho Kadono - Saitama Medical University

Yuho Kadono

Saitama Medical University, East Asia
Shintaro Hirata - Hiroshima University Hospital

Shintaro Hirata

Hiroshima University Hospital, East Asia
Meiping Lu - Department Of Rheumatology Immunology And Allergy

Meiping Lu

Department Of Rheumatology Immunology And Allergy, Children's Hospital Of Zhejiang University , Hangzhou, East Asia, East Asia
Hiroaki Dobashi - Kagawa University Hospital

Hiroaki Dobashi

Kagawa University Hospital, East Asia
Andrea Low - Southeast Asia General Hospital

Andrea Low

Southeast Asia General Hospital, Duke-national University Of Southeast Asia Medical School, Southeast Asia
Binit Vaidya - NATIONAL CENTER FOR RHEUMATIC DISEASES

Binit Vaidya

NATIONAL CENTER FOR RHEUMATIC DISEASES, South Asia